Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 462 participants.

Also called NCT07747402

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 462 participants (planned count) (from the registry)
Sponsor
Xi'an International Medical Center Hospital (from the registry)
Registry
  • NCT NCT07747402
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07747402. Randomized; no masking; primary purpose treatment. Start 2027-01 (anticipated); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Intervention (Drug)
Insulin icodec
Lead sponsor
Xi'an International Medical Center Hospital (class: other)

Record details

Record id
cardio:ct-nct07747402
Content hash
372d8bc36b1449f9b1689d3fd125ae041b1634d32d710b6c059ffed93647bd51